General Medical News
Designer Lymph nodes will give patients new immune system to fight cancer and increase vaccine potency 
Moffitt Cancer Center, in collaboration with researchers at Scripps Florida in Jupiter, has been awarded a five-year, nearly $2 million grant from the National Cancer Institute to design lymph nodes for cancer immunotherapy.
A patient diagnosed with cancer has a dysfunctional immune system either because of the tumor or the treatment being used to eradicate the [...]
Scientists Identify Chemical in Bananas as Potent Inhibitor of HIV Infection
A potent new inhibitor of HIV, derived from bananas, may open the door to new treatments to prevent sexual transmission of HIV, according to a University of Michigan Medical School study published this week. Scientists have ...
A potent new inhibitor of HIV, derived from bananas, may open the door to new treatments to prevent sexual transmission of HIV, according to a University of Michigan Medical School study published this week. Scientists have ...
Acura Pharmaceuticals, Inc. Announces Investigational New Drug Application
Acura Pharmaceuticals, Inc. today announced clinical evaluation is now allowed under an Investigational New Drug application ("IND") filed with the U.S. Food and Drug Administration ("FDA") for a benzodiazepine product candidate utilizing our Aversion® Technology. ...
Acura Pharmaceuticals, Inc. today announced clinical evaluation is now allowed under an Investigational New Drug application ("IND") filed with the U.S. Food and Drug Administration ("FDA") for a benzodiazepine product candidate utilizing our Aversion® Technology. ...
Nanosphere Verigene SP Respiratory Virus Panel Categorized as Moderate Complexity by FDA
Nanosphere, Inc., received notification from the U.S. Food and Drug Administration (FDA) that its respiratory virus panel (RVNATSP) performed on the Verigene SP System has been categorized as "Moderate Complexity" under the Clinical Laboratory Improvement ...
Nanosphere, Inc., received notification from the U.S. Food and Drug Administration (FDA) that its respiratory virus panel (RVNATSP) performed on the Verigene SP System has been categorized as "Moderate Complexity" under the Clinical Laboratory Improvement ...
ReNu MultiPlus Multi-Purpose Solution Named “Best Eye Care Product of the Year – Asia” by 2010 A.S. Watson’s Global Awards
Bausch + Lomb ReNu MultiPlus(R) multi-purpose solution has been named "Best Eye Care Product of the Year - Asia" for its revolutionary bottle design at this year's A.S. Watson Global Suppliers Awards. Held in Hong ...
Bausch + Lomb ReNu MultiPlus(R) multi-purpose solution has been named "Best Eye Care Product of the Year - Asia" for its revolutionary bottle design at this year's A.S. Watson Global Suppliers Awards. Held in Hong ...
Designer Lymph nodes will give patients new immune system to fight cancer and increase vaccine potency
Moffitt Cancer Center, in collaboration with researchers at Scripps Florida in Jupiter, has been awarded a five-year, nearly $2 million grant from the National Cancer Institute to design lymph nodes for cancer immunotherapy. A patient diagnosed ...
Moffitt Cancer Center, in collaboration with researchers at Scripps Florida in Jupiter, has been awarded a five-year, nearly $2 million grant from the National Cancer Institute to design lymph nodes for cancer immunotherapy. A patient diagnosed ...
Sun Pharma Announces USFDA Approval for Generic Prometh Syrup
Sun Pharmaceutical Industries Ltd. announced that the USFDA has granted its subsidiary an approval for its ANDA for Promethazine Hydrochloride and Codeine Phosphate Oral Syrup, 6.25 mg/5 ml and 10mg/5ml. This Promethazine Hydrochloride with Codeine Phosphate ...
Sun Pharmaceutical Industries Ltd. announced that the USFDA has granted its subsidiary an approval for its ANDA for Promethazine Hydrochloride and Codeine Phosphate Oral Syrup, 6.25 mg/5 ml and 10mg/5ml. This Promethazine Hydrochloride with Codeine Phosphate ...
